PharmaVOICE - 
Nov./Dec. 2017
Purchase Issue

In Every Issue
Letter from the Editor
Warp Speed Ahead It’s that time of year again — [...]
By

Taren Grom, Editor

Upfront
Pfizer Service Provides Social Workers for Patients Pfizer Oncology Together [...]
By

PharmaVOICE Staff

HealthTech
LivaNova Receives FDA Approvals for SenTiva Device for Treatment of [...]
By

PharmaVOICE Staff

Last Word
Digital Health Initiatives Georgia Mitsi, Senior Director, Search Evaluation & [...]
By

Georgia Mitsi, Senior Director, Search Evaluation & Digital Health Care Initiatives, Sunovion Pharmaceuticals,

On The Cover

Trend Tracking
In this special — 2018 Year in Preview — issue, PharmaVOICE’s thought leaders are tackling 10 trends that are expected to incite change in the year ahead. We will be looking at a variety of disparate topics that range from molecule to market in keeping with our publishing focus and philosophy: 2018 Year in Preview [...]
By

Taren Grom

Features

Trending 2018: What Does the Future Hold?
We tasked the PharmaVOICE 100 community of industry executives to think about some of the most important trends they expect will challenge the status quo, move the industry forward, and contribute to breakthroughs in medicine and business models. Their thoughtful insights signal the multitude of challenges and opportunities that lie ahead in the coming year. [...]
By

Taren Grom, Editor

Trending 2018: Agile Marketing
Agile methodology is all about leveraging experiences and failures to improve a process, and has been adopted across industries and entities to organize everything from software development to household chores and family activities. Rooted in IT, the agile manifesto has been adopted by winemakers, tractor manufacturers, public radio, and parents. By taking people — employees [...]
By

Robin Robinson

Trending 2018: Alternative Delivery
Point and click — could ordering your prescription drugs be as easy as that? Some experts say yes, some say we’ll see. But there is one thing for sure: the retail pharmacy world is changing. And one disrupter — Amazon — is in the middle of it all. And with Amazon’s mass distribution system, the [...]
By

Taren Grom, Editor

Trending 2018: Artificial Intelligence
Artificial intelligence (AI) in health represents a collection of multiple technologies, enabling machines to sense, comprehend, act, and learn so they can perform administrative and clinical healthcare functions. There are different applications of AI and machine learning in pharma, including disease identification/diagnosis, personalized treatment/behavioral modification, drug discovery/manufacturing, radiology and radiotherapy, smart electronic health records, epidemic [...]
By

Taren Grom, Editor

Trending 2018: Bioethics
New technologies for gene editing have created excitement about the potential for cures for diseases, as well as debates around ethics and regulatory oversight that are sure to dominate this field of science for years to come. CRISPR-Cas9, the newest gene-editing tool, is getting a lot of attention. It uses a protein-RNA complex that has [...]
By

Denise Myshko

Trending 2018: Brand Engagement
As patients start to manage their health through digital devices, not only does the pharma industry need to be more patient-centric, but the brand story must focus on the patient and his or her journey to create true brand engagement. According to a report from DRG Digital, as the pharmaceutical industry shifts its commercial model [...]
By

Robin Robinson

Trending 2018: Pipeline Disrupters
In recent years, several therapeutic disruptors have hit the market, pushing aside current standard treatment protocols. From hepatitis C cures to immuno-oncology therapies, recent approvals have upended how diseases are treated, providing patients with significant advances. Pharmaceutical, biotech, and biopharma companies are working on tomorrow’s disrupters. With more than 7,000 medicines in development around the [...]
By

Denise Myshko

Trending 2018: Rare Diseases
In recent years, a growing number of companies have entered the rare disease space, bolstered by regulatory incentives, such as the Orphan Drug Act, and scientific breakthroughs. While each rare disease has a relatively small patient population — defined in the United States as affecting fewer than 200,000 people — collectively the approximately 7,000 rare [...]
By

Kim Ribbink

Trending 2018: Real-World Outcomes
Real-word outcomes is not a new trend by any means, but it’s a market-changing model that is coming into its own and worthy of covering. That’s because the pharmaceutical market continues to shift to an outcomes-based reimbursement system, driven by payers’ need to rein in rising drug prices, advances in health technology, new data sources, [...]
By

Denise Myshko

Trending 2018: Treatment to Wellness
Attitudes about treating disease are undergoing a fundamental shift as the life-sciences industry faces pressure to demonstrate value. Increasingly, there is a move from treatment to prevention, diagnostics and cure, which KPMG says is leading to the rise of new competitors. By 2030, practitioners will be able to predict the likelihood of a patient being [...]
By

Kim Ribbink

Trending 2018: Virtual Health Technology
Someday, a bandage controlled by a smart phone could heal chronic wounds. Soon, a body-on-a-chip system could reduce the use of animal testing and more speedily advance personalized medicine. These are just two examples of how innovative technology is creating a new healthcare ecosystem, one in which the pharma industry will have to stretch its [...]
By

Robin Robinson

SHOWCASE FEATURE: eSolutions: Digital Takes Center Stage
Recent trends suggest that pharma companies will continue to invest in digital solutions and partner with innovative technology companies to inform business and clinical decision-making. Yet according to McKinsey, many pharma executives find it hard to determine which digital initiatives to scale up and how. The priority for companies will be to assess which technologies [...]
By

PharmaVOICE Staff

Picture This: Managing the Entire Lifecycle of Clinical Trial Images in a Single Tool
One of the great promises of technology is that it can simplify our lives. The need for it to do so is particularly strong in clinical research, where trials have been growing ever more complex. This is due, in part, to regulators’ increasing requests for the inclusion of imaging analysis when evaluating clinical trial data. [...]
By

Tim Kulbago, Vice President, Imaging, ERT

Digital Solutions That Make Sense to Support Sales Team Initiatives
Personal detailing by pharmaceutical sales representatives to physicians and other healthcare professionals has traditionally been the foremost effective way of brand marketing. Reportedly, pharmaceutical companies’ per capita spend on personal detailing visits exceeds direct-to-consumer marketing efforts, research, and development of new products. The sales detail appointment typically consists of a visit where the benefits of [...]
By

Brandie Lifante, VP Engagement Strategy, Digital, Ogilvy CommonHealth Worldwide, a WPP Health & Wellness company

Speak Out
Innovations in Alzheimer’s Clinical Trial Design Promise to Reduce Time, Risk by Allison House, Therapeutic Strategy Lead, Neuroscience, Worldwide Clinical Trials and Natalia Drosopoulou, Senior Director, Global Project Management, Neuroscience, Worldwide Clinical Trials The global impact of Alzheimer’s disease continues to increase. By 2050, The Alzheimer’s Association expects the number of people diagnosed with dementia [...]
By

Allison House, Therapeutic Strategy Lead, Neuroscience, Worldwide Clinical Trials and Natalia Drosopoulou, Senior Director, Global Project Management, Neuroscience, Worldwide Clinical Trials

Red Zone: Healing Patients With Digital Warmth: A Prescription for Life Sciences
Earlier this year, ReD Associates and Cognizant conducted an extensive research that cut across disease areas to understand how patients heal – that is, what happens when people face a health risk or issue and need to manage or overcome it. By participating in people’s everyday lives, we found that most patient experience the US [...]
By

Bhaskar Sambasivan, SVP & Global Markets Leader, Cognizant Life Sciences

Red Zone: safety portal: Increasing Patient Safety While Reducing Cost and Complexity
Although it sounds straightforward, global safety reporting of clinical trial adverse events is complicated, time-consuming and extremely expensive. Despite the substantial investment of time and money, research shows that global safety reporting is not protecting patients as well as it could. Driven by fear of regulatory non-compliance, along with a lack of sophisticated algorithms to [...]
By

Steven Beales, SVP, IT & Market Owner, Safety Solutions, ePharmaSolutions

Red Zone: Leveraging Behavioral Economics to Guide Healthy Decision-Making
People living with long-term health conditions make many decisions about their health, often on a daily basis, including whether to adhere to prescribed treatments. What insights from the world of psychology can help us create effective programs that guide healthy decision-making around adherence? One important insight is a fundamental tenet from the discipline of behavioral [...]
By

Kate Perry, MSC, PsychD, Director, Behavioral Science, Atlantis Healthcare

Red Zone: Innovation in Hematopoietic Cell Transplantation and Gene and Cellular Therapies Drive Results in Pediatric Oncology
This is an exciting time in medicine, providing more novel treatments for patients with cancer blood disorders. Scientists are learning more about the human genome and its role in disease. This knowledge allows investigators to develop new diagnostic tools and therapeutic interventions to more specifically treat individual diseases. We are now identifying ways to correct [...]
By

Medpace

FEEDBACK